Intrinsiqq
Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc. (ALHC) Insider Trading

Last 12 months

Insiders bought $198k and sold $108M on the open market.

76% of the selling was scheduled in advance under 10b5-1 plans. Chief Executive Officer John E Kao sold $11.4M on Dec 29, 2025, 12% of their stake, outside a plan.

Net open-market
−$108M
1 buy · 58 sales
Under a 10b5-1 plan
76%
of the value sold
Insiders who bought / sold
1 / 9
executives and directors
Last open-market buy
Jun 2026
Jun 2, 2026

Get an email when ALHC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 6No plan
    Hyong Kim
    Chief Medical Officer · sold 32,479 at $8.30
    $270k
    9.8% of stake
  • Sep 17No plan
    Joseph S Konowiecki
    EVP, Corporate Affairs · sold 23,511 at $8.61
    $202k
    2.1% of stake
  • Sep 1410b5-1 plan
    John E Kao
    Chief Executive Officer · sold 27,400 at $13.00
    $356k
    1.5% of stake
  • Sep 11No plan
    Dawn Christine Maroney
    President · sold 122,707 at $12.68
    $1.56M
    13% of stake
  • Sep 10 – 1110b5-1 plan
    John E Kao
    Chief Executive Officer · sold 557,870 at avg $12.77
    $7.12M
    23% of stake
  • Aug 1410b5-1 plan
    Dawn Christine Maroney
    President · sold 5,000 at $14.00
    $70k
    0.5% of stake
  • Aug 1010b5-1 plan
    John E Kao
    Chief Executive Officer · sold 298,000 at $13.88
    $4.14M
    11% of stake
  • Jul 1510b5-1 plan
    Dawn Christine Maroney
    President · sold 177,068 at $20.83
    $3.69M
    16% of stake
  • Jul 1010b5-1 plan
    John E Kao
    Chief Executive Officer · sold 298,000 at avg $19.86
    $5.92M
    9.9% of stake
  • Jul 110b5-1 plan
    Joseph S Konowiecki
    EVP, Corporate Affairs · sold 25,000 at $24.00
    $600k
    2.2% of stake
  • Jun 2610b5-1 plan
    Joseph S Konowiecki
    EVP, Corporate Affairs · sold 25,000 at $23.00
    $575k
    2.2% of stake
  • Jun 1810b5-1 plan
    Joseph S Konowiecki
    EVP, Corporate Affairs · sold 25,000 at $22.00
    $550k
    2.1% of stake
  • Jun 1510b5-1 plan
    Dawn Christine Maroney
    President · sold 30,000 at $19.55
    $587k
    3.1% of stake
  • Jun 1210b5-1 plan
    Hyong Kim
    Chief Medical Officer · sold 35,951 at $19.86
    $714k
    9.8% of stake
  • Jun 1110b5-1 plan
    Joseph S Konowiecki
    EVP, Corporate Affairs · sold 25,000 at $21.00
    $525k
    2.1% of stake
  • Jun 1010b5-1 plan
    John E Kao
    Chief Executive Officer · sold 298,000 at avg $20.36
    $6.07M
    9.0% of stake
  • Jun 2
    Mark D. Kent
    President - MSO · bought 14,848 at $13.31
    $198k
    New position
  • May 1510b5-1 plan
    Dawn Christine Maroney
    President · sold 30,000 at $16.09
    $483k
    3.0% of stake
  • May 1110b5-1 plan
    John E Kao
    Chief Executive Officer · sold 298,000 at avg $16.89
    $5.03M
    8.3% of stake
  • Apr 1510b5-1 plan
    Dawn Christine Maroney
    President · sold 30,000 at $20.87
    $626k
    2.8% of stake
  • Apr 10 – 1310b5-1 plan
    John E Kao
    Chief Executive Officer · sold 298,000 at avg $20.68
    $6.16M
    7.7% of stake
  • Apr 7No plan
    James M Head
    Chief Financial Officer · sold 11,100 at $21.08
    $234k
    6.0% of stake
  • Apr 710b5-1 plan
    John E Kao
    Chief Executive Officer · sold 250,000 at avg $21.01
    $5.25M
    6.0% of stake
  • Apr 110b5-1 plan
    Christopher J Joyce
    Chief Legal and Admin. Officer · sold 18,013 at $17.79
    $320k
    5.6% of stake
  • Mar 2310b5-1 plan
    John E Kao
    Chief Executive Officer · sold 118,000 at $17.48
    $2.06M
    2.8% of stake
  • Mar 18 – 1910b5-1 plan
    Andreas P. Wagner
    Chief Human Resources Officer · sold 23,602 at avg $18.03
    $425k
    14% of stake
  • Mar 18No plan
    Sebastian Burzacchi
    COO - Mgmt Services Org · sold 15,361 at $17.84
    $274k
    5.6% of stake
  • Mar 18No plan
    Hyong Kim
    Chief Medical Officer · sold 18,404 at $17.84
    $328k
    4.8% of stake
  • Mar 18No plan
    Christopher J Joyce
    Chief Legal and Admin. Officer · sold 25,125 at $17.84
    $448k
    7.2% of stake
  • Mar 18No plan
    Dawn Christine Maroney
    President · sold 36,749 at $17.84
    $656k
    3.4% of stake
  • Mar 18No plan
    John E Kao
    Chief Executive Officer · sold 73,046 at $17.84
    $1.3M
    1.7% of stake
  • Mar 18No plan
    Robert L. Scavo
    Chief Information Officer · sold 11,285 at $17.84
    $201k
    2.3% of stake
  • Mar 1610b5-1 plan
    Dawn Christine Maroney
    President · sold 30,000 at $17.48
    $524k
    2.7% of stake
  • Mar 12No plan
    Robert L. Scavo
    Chief Information Officer · sold 4,044 at avg $17.45
    $71k
    0.8% of stake
  • Mar 12No plan
    Dawn Christine Maroney
    President · sold 29,113 at avg $17.45
    $508k
    2.9% of stake
  • Mar 12No plan
    John E Kao
    Chief Executive Officer · sold 48,899 at avg $17.45
    $853k
    1.2% of stake
  • Mar 1010b5-1 plan
    John E Kao
    Chief Executive Officer · sold 180,000 at $18.19
    $3.27M
    4.3% of stake
  • Mar 410b5-1 plan
    Andreas P. Wagner
    Chief Human Resources Officer · sold 21,118 at $18.62
    $393k
    12% of stake
  • Feb 1710b5-1 plan
    Dawn Christine Maroney
    President · sold 30,000 at $20.63
    $619k
    2.9% of stake
  • Feb 10No plan
    Andreas P. Wagner
    Chief Human Resources Officer · sold 22,238 at $20.47
    $455k
    12% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ALHC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Hospital & Medical Service Plans

Spot a number that looks wrong? Check it in ALHC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ALHC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.